EMJ Gastroenterology 11 [Supplement 3] . 2022

In this issue

The production of TNFα during chronic inflammation leads to organ damage due to excessive inflammation. As the first in a series of articles exploring the value of tumour necrosis factor inhibitors (anti-TNFs) in treating immune-mediated disease, this review delved into the use of these therapies for inflammatory conditions, analysing their associated safety in pregnancy.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.